Lima Cavalcanti, Iago Dillion, Analúcia Guedes Silveira Cabral, and Rosiel José dos Santos. 2017. “Adverse Reactions for the Use of the Monoclonal Trastuzumab Antibody in the Treatment of Patients With HER2 Positive Breast Cancer”. Ars Pharmaceutica (Internet) 58 (4):171-74. https://doi.org/10.30827/ars.v58i4.6766.